A CCR5-dependent novel mechanism for type 1 HIV gp120 induced loss of macrophage cell surface CD4

Journal of Immunology

Volumn 166, Issue 8, 2001, Pages 4835-4842

  Hewson, T J ^a   Logie, J J ^a   Simmonds, P ^a   Howie, S E M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; GLYCOPROTEIN GP 120; HLA DR ANTIGEN; MESSENGER RNA;

ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MACROPHAGE ACTIVATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035871755     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.8.4835     Document Type: Article

References (55)

1. Immunopathogenesis of AIDS
2. Decreased T-cell proliferative response to common environmental antigens could be an indicator of early human immunodeficiency virus-mediated lymphocyte lesions
3. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome
4. Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection
5. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children
6. Analysis of autoantibodies to T-cell receptors among HIV-infected individuals: Epitope analysis and time course
7. Human immunodeficiency virus type 1 glycoprotein 120-specific T lymphocytes provide intermolecular help for anti-CD4 autoantibody production in exposed uninfected subjects
8. Induction of β-interferon by human-immunodeficiency-virus type-1 and its gp120 protein in human monocytes-macrophages: Role of β-interferon in restriction of virus-replication
9. Autoimmune T-cell response to the CD4 molecule in HIV-infected patients
10. HIV target-cells: Effect of their infection by HIV on the pathogenesis of AIDS
11. Interactions of HIV-1 with antigen-presenting cells
12. Antigen presenting cell function in HIV-1-infected patients
13. Envelope glycoproteins of human immunodeficiency virus type 1: Profound influences on immune functions
14. + T cells
15. + T lymphocytes and preferential loss of memory cells on interaction of mononuclear cells with HIV-1 glycoprotein-expressing cells
16. The effects of HIV gp120 on the expression of antigen presenting cell (APC) surface molecules
17. + T cell anergy
18. HIV-1 envelope glycoprotein gp120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor-α
19. HIV-1 envelope protein (gp120) inhibits the activity of human bronchoalveolar macrophages against Cryptococcus neoformans
20. Interleukin-12: A bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency
21. The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals
22. Adenovims-mediated human immunodeficiency virus-1 Nef expression in human monocytes/macrophages and effect of Nef on downmodulation of Fcγ receptors and expression of monokines
23. HIV nef: The mother of all evil?
24. Human-immunodeficiency-virus type-1 nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4
25. Human-immunodeficiency-virus type-1 vpu protein induces rapid degradation of CD4
26. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
27. HIV-1 envelope determinants for cell tropism and chemokine receptor use
28. Chemokine receptors in HIV-1 and SIV infection
29. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
30. Oligomerization of CD4 is required for stable binding to class-II major histocompatibility complex proteins but not for interaction with human-immunodeficiency-virus gp120
31. The protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of CD4 into coated pits
32. CD4: A co-receptor in the immune response and HIV infection
33. Interleukin 16 and its function as a CD4 ligand
34. T cell-tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: Implications for HIV pathogenesis
35. A CD4-independent interaction of human immunodeficiency virus-1 gp120 with CXCR4 induces their cointernalization, cell signaling, and T-cell chemotaxis
36. CD4 ligand IL-16 inhibits the mixed lymphocyte reaction
37. CD4 modulation of noninfected human T-lymphocytes by HIV-1 envelope glycoprotein gp120: Contribution to the immunosuppression seen in HIV-1 infection by induction of CD4 and CD3 unresponsiveness
38. HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral-blood monocytes
39. + T cells
40. HIV-1 envelope protein gp120 affects phenotype and function of monocytes in-vitro
41. Lipopolysaccharide (LPS) down-regulates CD4 expression in primary human macrophages through induction of endogenous tumor-necrosis-factor (TNF) and IL-1-β
42. Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxy vitamin-D3
43. Complete nucleotide-sequence of the AIDS virus, HTLV-III
44. Envelope sequences of 2 new United-States HIV-1 isolates
45. Minimal requirements for the human-immunodeficiency-virus type-1 V3 domain to support the syncytium-inducing phenotype: Analysis by single amino-acid substitution
46. Phenotype-associated sequence variation in the 3rd variable domain
47. A functional, discontinuous HIV-1 gp120 C3/C4 domain-derived, branched, synthetic peptide that binds to CD4 and inhibits MIP-1α chemokine binding
48. Cell labelling
49. Identification and characterization of monoclonal-antibodies specific for polymorphic antigenic determinants within the V2 region of the human-immunodeficiency-virus type-1 envelope glycoprotein
50. AIDS: Newer concepts in the immunopathogenic mechanisms of human-immunodeficiency-virus disease
51. Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1
52. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells
53. Constitutive cell surface association between CD4 and CCR5
54. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients
55. Antibody-dependent enhancement of HIV-1 infection in human term syncytiotrophoblast cells cultured in-vitro